KPV

Buy KPV Online

KPV is a short tripeptide derived from the C-terminal portion of alpha-MSH and is primarily researched for anti-inflammatory, gut, skin, and immune-regulation applications.

Product Information

KPV consists of lysine, proline, and valine. Research has examined its ability to influence inflammatory signaling in epithelial and immune-related cells.

How It Works

KPV can interfere with inflammatory signaling pathways, including NF-κB, reducing inflammatory chemokine and cytokine activity in experimental cell models.

POTENTIAL BENEFITS

1. Anti-Inflammatory Research

KPV has demonstrated strong anti-inflammatory activity in laboratory models, particularly through suppression of NF-κB-related inflammatory signaling.

2. Gut Health Research

KPV has attracted significant attention in gastrointestinal research, including experimental models investigating intestinal inflammation and mucosal integrity.

3. Skin Research

Because inflammatory signaling plays a major role in skin irritation and tissue damage, KPV is also being explored in dermatological and epithelial research.

4. Immune-Modulation Research

KPV may influence inflammatory signaling without acting as a broad immune suppressant, making its selective signaling properties particularly interesting.

5. Barrier-Function Research

Research into KPV has examined epithelial responses and inflammatory processes relevant to maintaining tissue-barrier integrity.

Dosage

There is no established clinical dosage for KPV. Online peptide discussions commonly report doses in the low hundreds of micrograms, but protocols vary significantly depending on route and formulation.

Side Effects

Human safety data are limited. Potential effects include local irritation, headache, gastrointestinal discomfort, or route-dependent reactions.

References

• Land SC. Inhibition of cellular and systemic inflammation cues in human bronchial epithelial cells by melanocortin-related peptides: mechanism of KPV action and a role for MC3R agonists. Inflamm Res. 2012. PMID: 22837805.
• Dalmasso G, Charrier-Hisamuddin L, Nguyen HTT, Yan Y, Sitaraman S, Merlin D. PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation. Gastroenterology. 2008;134(1):166-178. PMID: 18061177.PubMed

Note: BehemothLabz does not sell this product. Purchase links on this page may direct you to third-party suppliers through affiliate links.

Please click here to see how purchases actually work on this site.